UBS Group’s Integrated Wellness Acquisition Corp Redeemable Warrants WEL.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-9,336
Closed -$140 10298
2024
Q2
$140 Sell
9,336
-1,057
-10% -$30 ﹤0.01% 9114
2024
Q1
$364 Sell
10,393
-14,223
-58% -$528 ﹤0.01% 8608
2023
Q4
$862 Buy
24,616
+22,786
+1,245% +$1.8K ﹤0.01% 8492
2023
Q3
$686 Buy
+1,830
New +$1.2K ﹤0.01% 8336
2022
Q3
Sell
-2,399
Closed 11112
2022
Q2
$0 Buy
2,399
+799
+50% +$200 ﹤0.01% 11124
2022
Q1
$1K Buy
+1,600
New +$572 ﹤0.01% 9965

Other funds holding WEL.WS

UBS Group's WEL.WS Position: Q3 2024 in Review

UBS Group sold out of Integrated Wellness Acquisition Corp Redeemable Warrants (WEL.WS) in Q3 2024, closing a stake of 9,336 shares — an estimated $140 sold.

UBS Group first reported a position in WEL.WS in Q1 2022 and held it in 6 quarters. The position peaked at $1K in Q1 2022. 23 funds tracked by Wall St. Rank hold WEL.WS as of Q3 2024.

  • UBS Group reported no remaining Integrated Wellness Acquisition Corp Redeemable Warrants position as of Q3 2024 after selling out during the quarter.
  • UBS Group sold 9,336 Integrated Wellness Acquisition Corp Redeemable Warrants shares in Q3 2024, an estimated $140.
  • UBS Group first reported a position in Integrated Wellness Acquisition Corp Redeemable Warrants in Q1 2022 and held it in 6 quarters.
  • UBS Group's Integrated Wellness Acquisition Corp Redeemable Warrants position peaked at $1K in Q1 2022.
  • 23 funds tracked by Wall St. Rank held Integrated Wellness Acquisition Corp Redeemable Warrants as of Q3 2024.

Based on UBS Group's 13F filing for Q3 2024, filed 14 Nov 2024.